Glioblastoma is the most aggressive form of brain cancer, and survival rates are measured in months.
In this episode, Michael Canney, PhD, chief scientific officer at Carthera, describes the ongoing SONOBIRD clinical trial that is using ultrasound to fight the disease.
Dr. Lyon is the associate clinical director of the high-intensity focused ultrasound unit and co-director of the Focused Ultrasound Centre of Excellence at the University of Oxford.
Learn about his work treating a variety of cancers and exploring how the technology can affect the immune system.
“The overwhelming sensation of violently having tremors for the past 10 years and then have them go completely away was an uncontrollable emotion. I sobbed tears of joy just knowing that they were gone.”
‒ Bobby Krause, after undergoing focused ultrasound treatment for Parkinson’s disease